A study conducted by Richard Vander Heide, MD, Ph.D., Professor and Director of Pathology Research at LSU Health New Orleans School of Medicine, and Marc Halushka, MD, Ph.D., Professor of Pathology at Johns Hopkins University School of Medicine, suggests myocarditis caused by COVID-19 may be a relatively rare occurrence. Their findings are published online in Cardiovascular Pathology.
Reports of the rate of COVID-19 myocarditis have varied widely, ranging from 60% among middle-aged and elderly recovered patients to 14% among recovered athletes.
“Although it is clear that COVID-19 impacts the heart and blood vessels, to date, it has been difficult to know how reproducible any changes are due to the relatively small sample size of most autopsy series,” notes Dr. Vander Heide.
The authors collected data from 277 autopsy cases to analyze cardiovascular pathological findings from patients who died from COVID-19 in nine countries around the world. The data from these autopsied hearts were published in 22 papers. After careful review, the authors determined that the rate of myocarditis found in these patients is between 1.4% and 7.2%.
“What we have learned is that myocarditis is not nearly as frequent in COVID-19 as has been thought,” says Dr. Halushka. “This finding should be useful for our clinical colleagues to reconsider how to interpret blood tests and heart radiology studies.”
“By bringing the data together from this large number of autopsy cases, we have better determined the spectrum of histologic findings,” adds Dr. Vander Heide. “Even a low myocarditis rate of 1.4% would predict hundreds of thousands of worldwide cases of myocarditis in severe COVID-19 due to the enormous numbers of infected individuals. Low rates of myocarditis do not indicate that individuals infected with SARS-CoV-2 are not having cardiovascular problems, but rather those complications are likely due to other stressors such as endothelial cell activation, cytokine storms, or electrolyte imbalances.”
The authors also created a “checklist” for pathologists to use going forward when evaluating COVID-19 at autopsy to provide consistency in investigating and reporting findings.
“This study demonstrates the importance of the autopsy in helping us determine what is occurring in the hearts of individuals passing away due to COVID-19,” concludes Dr. Halushka.
Follow the latest news on the coronavirus (COVID-19) outbreak
Marc K. Halushka et al, Myocarditis is rare in COVID-19 autopsies: Cardiovascular findings across 277 post-mortem examinations, Cardiovascular Pathology (2020). DOI: 10.1016/j.carpath.2020.107300
Study shows myocarditis linked to COVID-19 not as common as believed (2020, October 29)
retrieved 29 October 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- Coronavirus cases worldwide top 60 million - November 26, 2020
- COVID Vaccine Rollout Could Begin Mid-December, Fauci Says - November 26, 2020
- बंदियों को एक बार में अधिकतम 300 दिवस की आपात छुट्टियों की रहेगी पात्रता - November 26, 2020
- Xofluza approved for postexposure prevention of flu - November 25, 2020
- Delirium May Be Only Sign of Severe COVID in Elderly: Study - November 25, 2020
- मुख्यमंत्री श्री चौहान 26 नवम्बर को एनर्जी स्वराज यात्रा का शुभारंभ करेंगे - November 25, 2020
- Space travel can adversely impact energy production in a cell - November 25, 2020
- AHA News: While Vacationing on an Isolated Island, She Had a Stroke - November 25, 2020
- भगवान बिरसा मुण्डा ने जनजातीय संस्कृति और देश की आजादी के लिए प्राणों की आहुति दी- मुख्यमंत्री श्री चौहान - November 25, 2020
- Why coronavirus rules should be about more than just stopping transmission - November 25, 2020